Anecortave acetate proving helpful for inhibiting CNV growth

Anaheim, CA-Anecortave acetate (Retaane, Alcon), a potent angiostatic agent, has been shown to be safe and superior to placebo in reducing loss of vision from baseline, avoiding severe vision loss, and inhibiting the growth of CNV membranes in patients with age-related macular degeneration (AMD), according to Jason S. Slakter, MD, who spoke during the American Academy of Ophthalmology annual meeting.